Decibel Cannabis acquires AgMedica, plans private placement
AgMedica’s facility should help beef Decibel’s export capabilities as it moves away from Canadian retail.
Canadian licensed producer Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) said Monday that it acquired AgMedica Bioscience Ltd. for a C$6.3 million unsecured convertible debenture.
The transaction adds AgMedica’s EU GMP and IMC-GAP certified annual flower production capacity of 5.1 metric tons per annum, bringing Decibel’s total exportable flower production to more than 12 metric tons annually when combined with its GACP facility, the news release noted.
Decibel CEO Benjamin Sze called the facility “the cornerstone of our international strategy” amid the Alberta-based firm’s latest leanings toward exports elsewhere across the Atlantic. The company sold off all of its Prairie Records retail stores earlier this year.
He added, “This marks the first step of Decibel’s new strategy as we execute on profitable growth opportunities enhanced by synergistic and accretive transactions.”
Decibel projects Ontario-based LP could contribute C$30 million of net revenue and C$4 million of EBITDA in 2025. On a pro-forma basis, Decibel anticipates total 2025 net revenue of C$130 million and adjusted EBITDA of C$25 million. The company said it paid an estimated 1.6x EBITDA multiple for AgMedica based on management’s 2025 projections.
Decibel also announced plans for a non-brokered private placement of common shares to raise between C$3 million to C$3.5 million, with terms to be determined and announced later.
The company gave a look-ahead at its third-quarter numbers next month as well, expecting net revenue between C$23 million to C$25 million and adjusted EBITDA of C$4 million to C$6 million. The guidance is based on its “new international exports within the quarter, sustained domestic sales, and new product launches.”
In August, Decibel posted a 22% year-over-year drop in net revenue to C$22.1 million, citing heightened competition in the infused pre-roll segment and a shift in vape consumer preferences.
Management said at the time that it paused capital spending and to focus on cost cuts ahead of new U.K. exports in the third quarter. Sze also noted positive “early indications” from relaunching the Qwest flower brand.
